Raymond James reiterates Alnylam stock Strong Buy on positive trial data
In
Investing.comBy Investing.com10/23/2026, 5:29:04 PM
EXECUTIVE SUMMARY
Raymond James reiterates Alnylam stock Strong Buy on positive trial data....
Key Takeaways
- Raymond James reiterates Alnylam stock Strong Buy on positive trial data.
Read Complete Original Article
Published originally on Investing.com
Related News
finance6 minutes ago
Oil markets are on edge ahead of the weekend, as midterm elections near and fresh U.S. strikes on Iran are predicted
Oil has climbed back to an Iran-war high and may soon go higher, if the U.S. and Israel strike Iran after their respective voters go to the polls in the coming days.
finance7 minutes ago
Oil prices climb as Saudi attacks heighten supply concerns - Oil & Gas Journal
Oil prices climb as Saudi attacks heighten supply concerns Oil & Gas Journal
finance13 minutes ago
RBC Capital reiterates Verisk Analytics stock rating at Outperform
RBC Capital reiterates Verisk Analytics stock rating at Outperform....
finance15 minutes ago
Newamsterdam Pharma stock hits 52-week low at 19.57 USD
Newamsterdam Pharma stock hits 52-week low at 19.57 USD....
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!